Staterra
Natural health product licensed in Canada
- Other names
- ProAction
- Licence holder
- Staterra Inc.
- NPN or DIN-HM
- 80075229
- Status
- Active licence
- Licence date
- 24 January 2017
- Revision date
- 11 April 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 24.99 µg a day according to the dosing instructions published by Health Canada (7 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 214.2 milligramme | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de potassium | 214.2 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Chondroïtin sulfate de sodium | 114.2 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 114.2 milligramme | Not calculated |
| Collagène hydrolysé Source : Poissons -Peau | 86 milligramme | Not calculated |
| Collagène hydrolysé Source : Collagène hydrolysé | 86 milligramme | Not calculated |
| Vitamine D Source : Cholécalciférol | 3.57 mcg | 24.99 µg |
| Calcium Source : Citrate de calcium | 28.6 milligramme | 200,200 µg |
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 1:10 Dry plant equivalent : 4.3 mg Potency : 40 % Boswellic acids | 43 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 7 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps to relieve joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80075229
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging